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012.05.0Abstract A patient with Budd–Chiari Syndrome who had Trans-jugular Intrahepatic Portosys-
temic Stent Shunt (TIPSS) performed with no improvement and was consequently put on the liver
transplant list. A non-obstructed channel up to the right atrium was created by opening the mis-
placed TIPSS stent and dilating supra-hepatic inferior vena cava stenosis. Marked clinical improve-
ment occurred with the patient losing ten kilograms of weight and both his lower limb edema and
ascites disappeared 6 weeks after the procedure. In this case percutaneous intervention averted the
need for liver transplantation.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Budd–Chiari syndrome is a clinical condition caused by
obstruction of the venous outﬂow of the liver. Its pathogenesis
is complex, usually involving an acquired thrombotic stimulus
associated with a genetic clotting abnormality producing
occlusion of the hepatic veins.1 Several treatments are avail-
able for the different stages and clinical manifestations of the
disease with liver transplantation being offered after more con-
ventional therapy, such as anticoagulation, diuretics or porto-
systemic shunts, had failed2 as was the case in this patient.rdiology Department, Faculty
assia Square, Abbasia 11566,
fax: +20 2 248 20 416.
.eg (M.A. El Missiri).
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A 20 year old male presented with a history of long standing
bilateral lower limb edema accompanied by progressive
abdominal swelling. He was thoroughly investigated and an
abdominal CT scan revealed signiﬁcant narrowing in all hepa-
tic veins with a web obstruction extending into the supra-hepa-
tic inferior vena cava (IVC) (Fig. 1). He was diagnosed as a
case of Budd–Chiari Syndrome due to heterozygous Factor
V leiden mutation. Transjugular Intrahepatic Portosystemic
Stent Shunt (TIPSS) was performed, and a 10 cm 8 French
stent was placed between the portal vein and IVC with no
improvement of the patient’s condition. An abdominal CT
scan performed six months later revealed that the stent was
misplaced as it was seen extending horizontally across the
IVC lumen and the already present supra-hepatic IVC narrow-
ing itself had not been tackled (Fig. 2).
On examination, the patient had bilateral wasting of tem-
poral muscles and mild pallor. Abdominal examination
revealed tense ascites with dilated veins visible over his ﬂanksg by Elsevier B.V. All rights reserved.
Figure 1 Abdominal CT scan prior to TIPSS procedure.
Figure 2 Abdominal CT scan six months after TIPSS stent.
Figure 3 Abdominal distension and visible veins on the ﬂanks
after TIPSS stent.
Figure 4 Venography showing the IVC obstruction above the
level of the renal veins.
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eral, pitting lower limb edema up to the level of his knees.
Laboratory investigations revealed microcytic hypochromic
anemia, with an International Normalized Ratio (INR) of 1.1.
His serum creatinine level was 1.1 mg/dL, total bilirubin was
1 mg/dL, albumin was 2.6 mg/dL, ASOT was 55 mg/dL, and
ALT was 66 mg/dL.
The patient was listed for liver transplant after failure of the
TIPSS procedure with persistence of symptoms.3 He had re-
quired repeated abdominal paracentesis nearly every week
and he was on diuretic therapy. We approached the patientwith the plan of percutaneous (transfemoral) intervention to
relieve the two levels of obstruction; the ﬁrst caused by the
endothelialized, misplaced TIPSS stent and the second in the
supra-hepatic portion of the IVC before its entry into the right
atrium. At ﬁrst the patient refused, but because of the long
waiting list, he ﬁnally gave his approval to perform the proce-
dure after 6 months.
2.1. Procedure
We aimed to create a non-obstructed channel up to the right
atrium. This would be achieved by opening a channel in the
misplaced TIPSS nitinol stent and dilating the suprahepatic
inferior vena cava (IVC) stenosis. We planned to deploy bal-
loon expandable stents at both sites.
After inserting a femoral sheath, venography revealed
obstruction of the IVC above the level of the renal veins
Figure 5 Venography showing that still no satisfactory results
were seen.
Figure 6 Maximal inﬂation with the 20 · 30 mm balloon show-
ing constriction at the level of TIPSS stent.
Figure 7 Final outcome with restoration of venous ﬂow without
signiﬁcant obstruction.
Figure 8 Scaphoid abdomen 6 weeks after second intervention
indicating relief of ascites.
Intervention instead of transplantation 257(Fig. 4). We started off by passing a zip wire through the IVC
obstruction and through the TIPSS stent to RA. After re-
peated trials, we also managed to pass a PTCA wire. The main
difﬁculties we faced during crossing the wires were caused by
the many tributaries and the TIPSS nitinol stent that crossed
horizontally in the IVC.
A 3.5 · 20 mm coronary balloon was then passed and in-
ﬂated at a pressure of 20 atmospheres to open a track. Afterthat we were able to pass a 4 · 30 mm peripheral balloon that
was inﬂated at a pressure of 14 atmospheres.
Minimal ﬂow improvement occurred (Fig. 5). At that point,
we decided to exchange the femoral sheath with an 11 French
long sheath with which we were able to introduce just below
the level of the TIPSS stent struts. This enabled us to dilate
using a 10 · 30 mm balloon after which we were able to intro-
duce the long sheath past the TIPSS stent struts, thus enabling
the passage of a 20 · 30 mm balloon which was repeatedly in-
ﬂated both at the level of supra-hepatic obstruction and at the
level of the TIPSS nitinol stent (Fig. 6), thus partially crushing
it.
We ﬁnished off with having full dilatation of the original
supra-hepatic IVC stenosis and to a lesser extent at the level
of the TIPSS stent (Fig. 7). It was decided to stop at this stage
and follow up the patient without stenting.
Rapid marked clinical improvement occurred. The patient
lost 10 kg and both his lower limb edema and ascites disap-
peared just 6 weeks after the procedure (Fig. 8). Abdominal
Figure 9 Abdominal CT scan after the second intervention
demonstrating disappearance of the collaterals which indicates
relief of obstruction.
258 M.A. Saleh et al.CT scan three months after the procedure revealed satisfactory
results with disappearance of the collaterals indicating relief of
obstruction (Fig. 9).
At present, after nine months of follow-up, the patient did
not require at any point to receive diuretic therapy and has no
lower limb edema or ascites.3. Discussion
Studies have shown that TIPSS dysfunction was mostly related
to stent restenosis or complete occlusion by thrombosis which
was corrected by angioplasty or restenting.4 There was also a
report of a stent being dislocated with its subsequent place-
ment into the right iliac vein.5
In our reporting of this case we aimed to display how per-
cutaneous intervention averted the need for liver transplanta-
tion in a patient with Budd–Chiari Syndrome with two levels
of obstruction; one caused by the disease itself and the other
iatrogenically caused by a previously misplaced TIPSS stent.
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